Association between early surgical intervention vs watchful waiting and outcomes for mitral regurgitation due to flail mitral valve leaflets

JAMA

Volumn 310, Issue 6, 2013, Pages 609-616

  Suri, Rakesh M ^a   Vanoverschelde, Jean Louis ^b   Grigioni, Francesco ^c   Schaff, Hartzell V ^a   Tribouilloy, Christophe ^d   Avierinos, Jean Francois ^e   Barbieri, Andrea ^f   Pasquet, Agnes ^b   Huebner, Marianne ^a,g   Rusinaru, Dan ^d   Russo, Antonio ^c   Michelena, Hector I ^a   Enriquez Sarano, Maurice ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d AMIENS UNIVERSITY HOSPITAL   (France)

^e AIX MARSEILLE UNIVERSITY   (France)

^f UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^g MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BELGIUM; COHORT ANALYSIS; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DISEASE REGISTRY; EARLY INTERVENTION; FEMALE; FOLLOW UP; FRANCE; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART VALVE SURGERY; HUMAN; INTERMETHOD COMPARISON; ITALY; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE REGURGITATION; MORTALITY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; RISK ASSESSMENT; SURVIVAL RATE; TRANSTHORACIC ECHOCARDIOGRAPHY; TREATMENT PLANNING; UNITED STATES; WATCHFUL WAITING;

EID: 84881466648     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2013.8643     Document Type: Article

References (23)

1. Suri RM, Burkhart HM, Daly RC, et al. Robotic mitral valve repair for all prolapse subsets using techniques identical to open valvuloplasty: establishing the benchmark against which percutaneous interventions should be judged. J Thorac Cardiovasc Surg. 2011;142(5):970-979.
2. Gammie JS, O'Brien SM, Griffith BP, Ferguson TB, Peterson ED. Influence of hospital procedural volume on care process and mortality for patients undergoing elective surgery for mitral regurgitation. Circulation. 2007;115(7):881-887.
3. Enriquez-Sarano M, Avierinos JF, Messika-Zeitoun D, et al. Quantitative determinants of the outcome of asymptomatic mitral regurgitation. N Engl J Med. 2005;352(9):875-883. (Pubitemid 40300296)
4. Grigioni F, Tribouilloy C, Avierinos JF, et al MIDA Investigators. Outcomes inmitral regurgitation due to flail leaflets: a multicenter European study. JACC Cardiovasc Imaging. 2008;1(2):133-141. (Pubitemid 351445406)
5. Kang DH, Kim JH, Rim JH, et al. Comparison of early surgery versus conventional treatment in asymptomatic severe mitral regurgitation. Circulation. 2009;119(6):797-804.
6. Ling LH, Enriquez-Sarano M, Seward JB, et al. Early surgery in patients with mitral regurgitation due to flail leaflets: a long-term outcome study. Circulation. 1997;96(6):1819-1825. (Pubitemid 27400739)
7. Enriquez-Sarano M, Sundt TM III. Early surgery is recommended formitral regurgitation. Circulation. 2010;121(6):804-811.
8. Gillam LD, Schwartz A. Primum non nocere: the case for watchful waiting in asymptomatic "severe" degenerative mitral regurgitation. Circulation. 2010;121(6):813-821.
9. Rosenhek R. Watchful waiting for severe mitral regurgitation. Semin Thorac Cardiovasc Surg. 2011;23(3):203-208.
10. Rosenhek R, Rader F, Klaar U, et al. Outcome of watchful waiting in asymptomatic severe mitral regurgitation. Circulation. 2006;113(18):2238-2244.
11. Montant P, Chenot F, Robert A, et al. Long-term survival in asymptomatic patients with severe degenerative mitral regurgitation: a propensity score-based comparison between an early surgical strategy and a conservative treatment approach. J Thorac Cardiovasc Surg. 2009;138(6):1339-1348.
12. Bonow RO, Carabello BA, Kanu C, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation. 2006;114(5):84-231.
13. Vahanian A, Baumgartner H, Bax J, et al. Guidelines on the management of valvular heart disease: the Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J. 2007;28(2):230-268. (Pubitemid 46276943)
14. Gillinov AM, Mihaljevic T, Blackstone EH, et al. Should patients with severe degenerative mitral regurgitation delay surgery until symptoms develop? Ann Thorac Surg. 2010;90(2):481-488.
15. Hlatky MA, Douglas PS, Cook NL, et al. Future directions for cardiovascular disease comparative effectiveness research: report of a workshop sponsored by the National Heart, Lung, and Blood Institute. J Am Coll Cardiol. 2012;60(7):569-580.
16. Tribouilloy C, Grigioni F, Avierinos JF, et al; MIDA Investigators. Survival implication of left ventricular end-systolic diameter inmitral regurgitation due to flail leaflets: a long-term follow-up multicenter study. J Am Coll Cardiol. 2009;54(21):1961-1968.
17. Lloyd-Jones DM, Larson MG, Leip EP, et al; Framingham Heart Study. Lifetime risk for developing congestive heart failure. Circulation. 2002;106(24):3068-3072.
18. Agricola E, Oppizzi M, De Bonis M, et al. Multiplane transesophageal echocardiography performed according to the guidelines of the American Society of Echocardiography in patients with mitral valve prolapse, flail, and endocarditis. J Am Soc Echocardiogr. 2003;16(1):61-66.
19. R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2012.
20. Hernán M, Brumback B, Robins J. Marginal structural models to estimate the joint causal effect of nonrandomized treatments. J Am Stat Assoc. 2001;96(454):440-448.
21. Robins JM, Hernán MA, Brumback B. Marginal structural models and causal inference in epidemiology. Epidemiology. 2000;11(5):550-560. (Pubitemid 30660034)
22. Concato J, Peduzzi P, Huang GD, et al. Comparative effectiveness research: what kind of studies do we need? J Investig Med. 2010;58(6):764-769.
23. Tietge WJ, de Heer LM, van Hessen MW, et al. Early mitral valve repair versus watchful waiting in patients with severe asymptomatic organicmitral regurgitation; rationale and design of the Dutch AMR trial, a multicenter, randomised trial. Neth Heart J. 2012;20(3):94-101.